Partnerships, Licensing, Investments and M&A Deals and Trends for February 2016 in Pharmaceuticals
SKU ID :GD-10157466 | Published Date: 01-Apr-2016 | No. of pages: 104Description
TOC
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2016 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2016 14
2.2.1 Mylan to Acquire Meda for USD9.9 Billion 14
2.2.2 GTCR to Form Joint Venture with Ed Fiorentino 16
2.2.3 Baxalta Enters into Agreement with Precision Biosciences 16
2.2.4 McKesson to Acquire Vantage Oncology and Biologics for USD1.2 Billion 17
2.2.5 Ipsen Enters into Licensing Agreement with Exelixis 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2016 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2016 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2016 21
3.1.1 Top M&A Deals in February 2016 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2015 - February 2016 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2016 25
3.2.1 Top Equity Offering Deals in February 2016 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2015 - February 2016 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2016 29
3.3.1 Top PE/VC Deals in February 2016 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2016 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2016 33
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2015-February 2016 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2015-February 2016 36
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2016 37
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2016 37
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2015 - February 2016 39
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 41
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2016 42
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 43
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2015 - February 2016 45
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2015 - February 2016 46
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 48
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2016 50
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2016 50
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 52
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2015 - February 2016 54
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2015 - February 2016 56
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2015 - February 2016 58
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2015 - February 2016 61
5.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2016 62
5.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2016 63
5.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2016 63
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 64
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2016 64
6.1.1 Oncology - Deals of the Month 66
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2016 68
6.2.1 Central Nervous System - Deals of the Month 70
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2016 71
6.3.1 Infectious Diseases - Deals of the Month 73
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2016 74
6.4.1 Cardiovascular - Deals of the Month 76
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2016 77
6.5.1 Immunology - Deals of the Month 78
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, February 2016 79
6.6.1 Gastrointestinal - Deal of the Month 81
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, February 2016 82
6.7.1 Metabolic Disorders - Deal of the Month 83
7 Deal Summary by Geography 84
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2016 84
7.1.1 North America - Deals of the Month 86
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2016 88
7.2.1 Europe - Deals of the Month 90
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2016 92
7.3.1 Asia-Pacific - Deals of the Month 93
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2016 95
7.4.1 Rest of the World - Deals of the Month 96
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 97
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2015 - February 2016 97
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2015 - February 2016 99
9 Further Information 101
9.1 Methodology 101
9.2 About GlobalData 102
9.3 Disclosure information 102
9.4 Disclaimer 103
Tables & Figures
1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 13
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, February 2016 14
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), February 2016 20
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 22
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, February 2016 22
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2015 - February 2016 24
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 26
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, February 2016 26
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 28
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 30
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, February 2016 30
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, September 2015 - February 2016 32
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), February 2016 34
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 36
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2015 - February 2016 36
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 38
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 40
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 42
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 42
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 44
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2015 - February 2016 47
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), September 2015 - February 2016 49
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 51
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 53
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 55
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), February 2016 57
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2015 - February 2016 60
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 62
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, February 2016 62
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, February 2016 63
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, February 2016 63
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 65
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 69
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 72
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 75
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 78
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 80
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 83
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 85
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 89
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 93
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 96
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 98
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 100
1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 12
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), February 2016 19
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), February 2016 20
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 21
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2015 - February 2016 23
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 25
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 27
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 29
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, September 2015 - February 2016 31
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), February 2016 33
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), February 2016 34
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 35
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 37
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 39
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 41
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 43
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2015 - February 2016 45
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, September 2015 - February 2016 46
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 48
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 50
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 52
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 54
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 - February 2016 56
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, September 2015 - February 2016 58
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), September 2015 - February 2016 59
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 61
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 64
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 68
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 71
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 74
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 77
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 79
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 82
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 84
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 88
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 92
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 95
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 97
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), September 2015 - February 2016 99
Companies
- PRICE
-
$1000$3000